Search results for "Sarcopenic obesity"

showing 9 items of 9 documents

Body composition as a predictor of physical performance in older age : A ten- year follow-up of the Helsinki Birth Cohort Study

2018

Background: This study assessed how different measures of body composition predict physical performance ten years later among older adults. Methods: The participants were 1076 men and women aged 57 to 70 years. Body mass index (BMI), waist circumference, and body composition (bioelectrical impedance analysis) were measured at baseline and physical performance (Senior Fitness Test) ten years later. Linear regression analyses were adjusted for age, education, smoking, duration of the follow-up and physical activity. Results: Greater BMI, waist circumference, fat mass, and percent body fat were associated with poorer physical performance in both sexes (standardized regression coefficient [beta…

MaleSarcopeniaAgingHealth (social science)Body compositionPhysical performanceCohort Studies0302 clinical medicineMedicine030212 general & internal medicineChildFinlandAdiposity2. Zero hungerINSULIN-RESISTANCELOWER-EXTREMITY PERFORMANCEIncidenceFUNCTIONAL IMPAIRMENTta3142X-RAY ABSORPTIOMETRYMiddle AgedPhysical Functional PerformanceC-REACTIVE PROTEINfyysinen kuntoFemaleBioelectrical impedance analysisikääntyneetCohort studyNATIONAL-HEALTHWaist030209 endocrinology & metabolismArticle03 medical and health scienceslean massHumansSarcopenic obesitySARCOPENIC OBESITYObesityExerciseAgedkehonkoostumusbusiness.industryLean massALTERNATIVE DEFINITIONSphysical performanceADULTSmedicine.diseaseObesitylihasmassa3121 General medicine internal medicine and other clinical medicineStandardized coefficientLean body masslihavuus3111 BiomedicineGeriatrics and GerontologybusinessGerontologyBody mass indexFollow-Up StudiesForecastingDemography
researchProduct

CARDIOMETABOLIC SYNDROME AND SARCOPENIC OBESITY IN OLDER PERSONS

2007

The aging of the world's population is a major contributor to the growing prevalence of the cardiometabolic syndrome (CMS) because older persons are more affected by the constellation of cardiovascular risk factors that constitute the syndrome. The prevalence of CMS has been related to the increasing prevalence of obesity, which is growing progressively even among older age groups. Indeed, obesity and aging are 2 overlapping mounting public health problems. It is currently accepted that CMS predicts cardiovascular mortality and/or the development of type 2 diabetes mellitus, and this is also true in studies including older persons. CMS is further complicated by modifications in body composi…

Gerontologymedicine.medical_specialtyAgingEndocrinology Diabetes and MetabolismPopulationAdipokineCardiometabolic syndromeInternal MedicinemedicineHumansSarcopenic obesityObesityeducationhealth care economics and organizationsAgedMetabolic Syndromeeducation.field_of_studybusiness.industryPublic healthType 2 Diabetes Mellitusmedicine.diseaseObesityMuscular AtrophyAdipose TissueCardiovascular DiseasesSarcopeniaLean body massPhysical therapyBody CompositionInflammation MediatorsInsulin ResistanceCardiology and Cardiovascular MedicinebusinessHuman
researchProduct

Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.

2014

Abstract Background/objectives Cachexia affects ∼80% of pancreatic cancer patients. An international consensus defines cachexia as an ongoing loss of skeletal muscle mass (sarcopenia) with or without loss of fat, which impairs body functioning and cannot be reversed by conventional nutritional measures. Weight loss percentage and elevated inflammation markers have been employed to define this condition earlier. This review aimed to assess the prevalence and consequences of cachexia and sarcopenia on survival in patients with pancreatic ductal adenocarcinoma. Methods The systematic review was performed by searching the articles with preset terms published in PubMed and Cochrane Database unti…

Oncologymedicine.medical_specialtySarcopeniaCachexiaEndocrinology Diabetes and MetabolismOverweightCachexiaWeight lossInternal medicinePancreatic cancerWeight LossmedicinePrevalenceHumansSarcopenic obesityHepatologybusiness.industryConfoundingGastroenterologymedicine.diseasePrognosismusculoskeletal systemPancreatic NeoplasmsSurvival RateCachexia/diagnosis/epidemiology/*etiology; Carcinoma Pancreatic Ductal/*complications/mortality; Humans; Pancreatic Neoplasms/*complications/mortality; Prevalence; Prognosis; Sarcopenia/diagnosis/epidemiology/*etiology; Survival Rate; Weight LossSarcopeniaAdenocarcinomamedicine.symptombusinessCarcinoma Pancreatic Ductal
researchProduct

Salivary Testosterone and Cortisol as Biomarkers for the Diagnosis of Sarcopenia and Sarcopenic Obesity in Community-Dwelling Older Adults

2021

Nowadays, the appearance of sarcopenia (S) or sarcopenic obesity (SO) is related to aging. According to the criteria of the European Working Group on Sarcopenia in Older People (EWGSOP), the feasibility of using salivary cortisol and testosterone levels was analyzed as diagnostic biomarkers of S or SO. One hundred and ninety non-institutionalized people aged &ge

GerontologiaWaistActivities of daily livingPhysiology030209 endocrinology & metabolismcommunity older adultscortisolBiologyArticleGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicinemedicineSarcopenic obesity030212 general & internal medicinelcsh:QH301-705.5General Immunology and MicrobiologyTestosterone (patch)Salivary testosteronemusculoskeletal systemmedicine.diseasebody regionslcsh:Biology (General)SarcopeniatestosteroneObesitatBiomarker (medicine)General Agricultural and Biological Scienceshuman activitiesBody mass indexBiology
researchProduct

A Research Agenda: The Changing Relationship Between Body Weight and Health in Aging

2008

aging sarcopenic obesity sarcopenia
researchProduct

Tomografía computarizada a nivel de C3 y dinamometría como técnicas de diagnóstico de sarcopenia en pacientes con cáncer de cabeza y cuello

2020

Introducción: Estudio piloto que determina el diagnóstico de sarcopenia mediante tomografía computarizada (TC) a nivel de la tercera vértebra cervical (C3) y dinamometría en pacientes con cáncer de cabeza y cuello. Comparación de la masa magra (MM) determinada mediante TC con técnicas clásicas de antropometría y dinamometría.Material y métodos: Se analizó la MM y el tejido adiposo mediante TC a nivel de C3 en 37 pacientes oncológicos mediante Unidades Hounsfield (UH). Posteriormente, se calculó el índice musculoesquelético (IME) y se determinó la fuerza prensora de mano para la determinación de sarcopenia. Por último, se comparó el IME mediante técnicas de valoración antropométrica clásica …

TomografíaSarcopeniaRC620-627Adipose tissueNeoplasias de Cabeza y CuelloPositive correlationVértebras Cervicales03 medical and health sciences0302 clinical medicineDinamómetro de Fuerza MuscularMúsculos del CuelloHounsfield scalemedicineTX341-641Sarcopenic obesity030212 general & internal medicineNutritional diseases. Deficiency diseasesNutrition and DieteticsNutrition. Foods and food supplybusiness.industryHead and neck cancerFuerza MuscularSkeletal muscleThird cervical vertebramedicine.diseasemedicine.anatomical_structure030220 oncology & carcinogenesisSarcopeniaNuclear medicinebusinessFood ScienceRevista Española de Nutrición Humana y Dietética
researchProduct

Sarcopenic obesity: definition, cause and consequences.

2008

PURPOSE OF REVIEW: Older obese persons with decreased muscle mass or strength are at special risk for adverse outcomes. We discuss potential pathways to muscle impairment in obese individuals and the consequences that joint obesity and muscle impairment may have on health and disability. Tantamount to this discussion is whether low muscle mass or, rather, muscle weakness should be used for the definition. RECENT FINDINGS: Excess energy intake, physical inactivity, low-grade inflammation, insulin resistance and changes in hormonal milieu may lead to the development of so-called 'sarcopenic obesity'. It was originally believed that the culprit of age-related muscle weakness was a reduction in…

Malemedicine.medical_specialtyAgingHealth StatusMedicine (miscellaneous)ComorbidityvanheneminenArticlesarcopeniaLow muscle massPhysical medicine and rehabilitationSDG 3 - Good Health and Well-beingClassification of obesityRisk FactorsmedicineHumansSarcopenic obesitysarkopeniaMuscle StrengthObesityExercise physiologyMuscle SkeletalExerciseAgedNutrition and Dieteticsbusiness.industryagingMuscle weaknessmedicine.diseaseComorbidityObesityMuscular AtrophyikääntyminenSarcopenia/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemalemedicine.symptombusinessCurrent Opinion in Clinical Nutrition and Metabolic Care
researchProduct

Sarcopenia and Covid-19: A New Entity?

2021

As the world comes into terms with the persistent existence of the coronavirus disease 19 (COVID-19) pandemic, the scientific and medical communities have started shifting their attention to the long-term side effects of the disease. Specialists have acknowledged that numerous COVID-19 survivors, especially those who suffered severe complications and endured prolonged bedrest, may require continuous monitoring and rehabilitative care. In this chapter, the authors discuss factors that may predispose individuals to acute sarcopenia secondary to COVID-19 infection or sarcopenic obesity secondary to altered diet and physical activity from prolonged confinement. Challenges in nutrition are highl…

medicine.medical_specialtyMuscle lossCoronavirus disease 2019 (COVID-19)business.industryPhysical activityDiseasemedicine.diseaseSarcopeniaPandemicmedicineMuscle strengthSarcopenic obesityIntensive care medicinebusiness
researchProduct

[Protein intake in community-dwelling postmenopausal women and its relationship with sarcopenia].

2021

Objectives: the general aging of the population is related to the increase in the prevalence of sarcopenic disease; especially among older women, this pathology is closely related to nutrition and specifically to protein consumption in older adults. The aim of our study was to evaluate the possible relationship between a low protein intake and a higher prevalence of sarcopenic disease, a worse dietary pattern, and lower physical performance in postmenopausal women living in the community. Material and methods: the study was carried out in a total of 164 independent women over 65 years of age, recruited from a municipal social center in Valencia (Benimaclet). The presence of sarcopenic patho…

SarcopeniaLow proteinPopulationMedicine (miscellaneous)DiseaseEnvironmental healthPrevalenceMedicineHumansSarcopenic obesityeducationAgedAged 80 and overeducation.field_of_studyNutrition and DieteticsPostmenopausal womenbusiness.industryMiddle AgedProtein intakeMicronutrientmedicine.diseasePostmenopauseSarcopeniaFemaleDietary ProteinsIndependent LivingbusinessEnergy IntakeNutricion hospitalaria
researchProduct